A Minnesota vascular access medical technology company announced that the Food and Drug Administration has cleared 28 sizes of a angioplasty balloon catheter that does not need viscous contrast media to be detected by physicians under an X-Ray.
The Vector Percutaneous Transluminal Angioplasty balloon catheter is made by r4 Vascular Inc. and contains “radiopaque stripes” such that a fluoroscopy does not need to be conducted to see it under an X-Ray. Instead physicians may use “low-viscosity saline which reduces inflation/deflation time up to 50% and may reduce x-ray exposure to the patient and clinicians,” the company said in a news release.
The company also develops products based on biomimetic coating technologies, imaging technologies and fluid modeling and analysis
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.
By Arundhati Parmar
Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.More posts by Author
- Get Livefyre
- FAQ
